Package 25021-207-51

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 25021-207-51
Digits Only 2502120751
Product NDC 25021-207
Product ID 25021-207_f327fef8-8ebd-45a2-a339-72e702c4f8b5
Description

1 VIAL in 1 CARTON (25021-207-51) / 100 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2013-10-31
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

doxorubicin hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f327fef8-8ebd-45a2-a339-72e702c4f8b5", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1191138", "1790100"], "spl_set_id": ["ae80bd3a-b99a-4e01-a444-b9d05687f00e"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-207-25)  / 25 mL in 1 VIAL", "package_ndc": "25021-207-25", "marketing_start_date": "20131031"}, {"sample": false, "description": "1 VIAL in 1 CARTON (25021-207-51)  / 100 mL in 1 VIAL", "package_ndc": "25021-207-51", "marketing_start_date": "20131031"}], "brand_name": "doxorubicin hydrochloride", "product_id": "25021-207_f327fef8-8ebd-45a2-a339-72e702c4f8b5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "25021-207", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "doxorubicin hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209825", "marketing_category": "ANDA", "marketing_start_date": "20131031", "listing_expiration_date": "20261231"}